Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Noaber

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 16
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 12
Rounds per year 0.70
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 1
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

  • Health Care
  • Medical
  • Fitness
  • Biotechnology
  • Hospital
Summary

In 2000 was created Noaber, which is appeared as VC. The main department of described VC is located in the Lunteren. The company was established in Europe in The Netherlands.

Among the various public portfolio startups of the fund, we may underline EarlySense, Ambient Clinical Analytics, LeQuest Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Association, Medical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2016. The common things for fund are deals in the range of 5 - 10 millions dollars. Opposing the other organizations, this Noaber works on 18 percentage points less the average amount of lead investments. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations.

The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Noaber, startups are often financed by Pitango Venture Capital, Vinnova, ProSeed Venture Capital Fund. The meaningful sponsors for the fund in investment in the same round are Pitango Venture Capital, Inventure, Welch Allyn. In the next rounds fund is usually obtained by Pitango Venture Capital, JK&B Capital, Wells Fargo Strategic Capital, Inc..

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Noaber:
Typical Co-investors
Noaber is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Noaber:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from The Netherlands
Funds with similar focus located in The Netherlands:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Alba Health

Health Care
$2M21 Jun 2023 -

Newsenselab (M-sense)

Apps
Health Care
mHealth
Therapeutics
20 Dec 2021 Berlin, Berlin, Germany

Elsa

Biotechnology
Fitness
Health Care
Life Science
Medical
Mobile
$4M05 Nov 2021 Stockholm, Stockholm County, Sweden

Sweetch

Artificial Intelligence
Health Care
Machine Learning
Medical
Mobile Apps
$20M19 Jul 2021 Jerusalem, Jerusalem District, Israel

Elsa

Biotechnology
Fitness
Health Care
Life Science
Medical
Mobile
$2M19 Jan 2020 Stockholm, Stockholm County, Sweden

Newsenselab (M-sense)

Apps
Health Care
mHealth
Therapeutics
$1M03 Dec 2019 Berlin, Berlin, Germany

NewCompliance

Health Care
Hospital
Medical
$3M19 Nov 2019 The Hague, Zuid-Holland, The Netherlands

Ambient Clinical Analytics

Analytics
Health Care
Medical
Software
$1M19 Jun 2018 Rochester, Minnesota, United States

Noona Healthcare

Health Care
Medical
Medical Device
$1M23 Nov 2016 Helsinki, Uusimaa, Finland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Noaber?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 16
Average round size 5M
Rounds per year 0.70
Peak activity year 2019
Lead investments 3
Follow on index 0.25
Exits 1
Group Appearance index 0.81

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Alba Health

Health Care
$2M21 Jun 2023 -

Newsenselab (M-sense)

Apps
Health Care
mHealth
Therapeutics
20 Dec 2021 Berlin, Berlin, Germany

Elsa

Biotechnology
Fitness
Health Care
Life Science
Medical
Mobile
$4M05 Nov 2021 Stockholm, Stockholm County, Sweden

Sweetch

Artificial Intelligence
Health Care
Machine Learning
Medical
Mobile Apps
$20M19 Jul 2021 Jerusalem, Jerusalem District, Israel

Elsa

Biotechnology
Fitness
Health Care
Life Science
Medical
Mobile
$2M19 Jan 2020 Stockholm, Stockholm County, Sweden

Newsenselab (M-sense)

Apps
Health Care
mHealth
Therapeutics
$1M03 Dec 2019 Berlin, Berlin, Germany

NewCompliance

Health Care
Hospital
Medical
$3M19 Nov 2019 The Hague, Zuid-Holland, The Netherlands

Ambient Clinical Analytics

Analytics
Health Care
Medical
Software
$1M19 Jun 2018 Rochester, Minnesota, United States

Noona Healthcare

Health Care
Medical
Medical Device
$1M23 Nov 2016 Helsinki, Uusimaa, Finland
Crunchbase icon

Content report

The following text will be sent to our editors: